Agios Pharmaceuticals (AGIO) Net Margin Growth (1y) (2013 - 2026)

Agios Pharmaceuticals (AGIO) Net Margin Growth (1y) (2013 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin Growth (1y) (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 1,491.00
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 1,120.00
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn -653.00
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 447.00
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 Agios Pharmaceuticals 2.13 Bn 2.13 Bn 19.43 Mn 56,518.00

Historic Data

Download Data
DateValue
Mar 31, 2026 56,518.00
Dec 31, 2025 35,847.00
Sep 30, 2025 -1.14 Mn
Jun 30, 2025 22,304.00
Mar 31, 2025 -9,624.00
Dec 31, 2024 45,113.00
Sep 30, 2024 1.18 Mn
Jun 30, 2024 5,814.00
Mar 31, 2024 37,067.00
Dec 31, 2020 27,115.00
Sep 30, 2020 35,937.00
Jun 30, 2020 40,717.00
Mar 31, 2020 36,852.00
Dec 31, 2019 130,686.00
Sep 30, 2019 22,038.00
Jun 30, 2019 -25,518.00
Mar 31, 2019 74,845.00
Dec 31, 2018 237,409.00
Sep 30, 2018 4,695.00
Dec 31, 2017 -373,248.00